Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Nsaids and Covid-19: A New Challenging Area Publisher



Baradaran H1 ; Hamishehkar H1 ; Rezaee H1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Source: Pharmaceutical Sciences Published:2020


Abstract

Considering the recent controversies regarding the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Coronavirus disease 2019 (COVID-19) patients, and due to the limited published data in this field, we reviewed currently available evidence for the use of NSAIDs in viral respiratory tract infections to help make decisions in this area. Currently, there is insufficient evidence to judge the safety and efficacy of NSAIDs in patients with COVID-19. According to the current evidence, acetaminophen is the choice treatment for symptomatic relief. If the patients' symptoms are not controlled by acetaminophen, naproxen may be used as an alternative therapy. © 2020 The Author(s). This is an open access article and applies the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, as long as the original authors and source are cited.
Other Related Docs
11. Factors Associated With the Poor Outcomes in Diabetic Patients With Covid-19, Journal of Diabetes and Metabolic Disorders (2020)
23. Case Fatality Rate of Covid-19: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Hygiene (2021)
27. Cardiovascular Manifestations in Covid-19 Patients: A Systematic Review and Meta-Analysis, Journal of Cardiovascular and Thoracic Research (2021)
38. Analyzing Trends in Demographic, Laboratory, Imaging, and Clinical Outcomes of Icu-Hospitalized Covid-19 Patients, Canadian Journal of Infectious Diseases and Medical Microbiology (2023)